Last week’s jobs report showed that wage growth continues to slow under Trump. At the same time, we learned that CEO pay for the top pharmaceutical companies topped $300 million last year.
Wage growth continues to slow and working Americans have fallen further behind under Trump.
New York Times: “Wage growth, which was already slowing from last year’s peak, was less impressive. Average hourly wages were up 0.2 percent, bringing down the year-over-year gains to 3 percent.”
The Daily Beast: “Trump’s ‘Spectacular Economy’ Was Far Better for the Middle Class Under Obama”
Washington Post: “There were a record 53 million low-wage workers last year, or about 44 percent of all active workers in the United States. More than half were women. Two-thirds were in their prime earning years. Forty percent were supporting children at home. They earned a median annual salary of $17,950.”
At the same time, the CEOs of 10 large pharmaceutical companies collectively made more than $300 million last year.
Axios: “10 major health care companies have filed preliminary or final disclosures outlining executive pay in 2019. The CEOs at those firms made more than $300 million collectively, according to our updated tracker of health care executive compensation.”
